Qube Research & Technologies (QRT)’s Verrica Pharmaceuticals VRCA Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VRCA Stock Details VRCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-5,296	Closed	-$28.1K	–	3986
2025 Q2	$28.1K	Buy	+5,296	New	+$28.5K	﹤0.01%	3226
2025 Q1	–	Sell	-3,526	Closed	-$24.7K	–	3913
2024 Q4	$24.7K	Sell	3,526 -28,693	-89%	-$315K	﹤0.01%	3166
2024 Q3	$467K	Buy	+32,219	New	+$1.45M	﹤0.01%	2293
2023 Q2	–	Sell	-5,409	Closed	-$352K	–	3076
2023 Q1	$352K	Buy	+5,409	New	+$327K	﹤0.01%	1690
2022 Q4	–	Sell	-1,102	Closed	-$32K	–	3040
2022 Q3	$32K	Sell	1,102 -33	-3%	-$1.13K	﹤0.01%	2223
2022 Q2	$22K	Buy	+1,135	New	+$57K	﹤0.01%	2255

Other funds holding VRCA

Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sovran Advisors San Diego, California $1.34B AUM 21.63% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VRCA Position: Q3 2025 in Review

Qube Research & Technologies (QRT) sold out of Verrica Pharmaceuticals (VRCA) in Q3 2025, closing a stake of 5,296 shares — an estimated $28.1K sold.

Qube Research & Technologies (QRT) first reported a position in VRCA in Q2 2022 and held it in 6 quarters. The position peaked at $467K in Q3 2024. 34 funds tracked by Wall St. Rank hold VRCA as of Q3 2025.

Qube Research & Technologies (QRT) reported no remaining Verrica Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
Qube Research & Technologies (QRT) sold 5,296 Verrica Pharmaceuticals shares in Q3 2025, an estimated $28.1K.
Qube Research & Technologies (QRT) first reported a position in Verrica Pharmaceuticals in Q2 2022 and held it in 6 quarters.
Qube Research & Technologies (QRT)'s Verrica Pharmaceuticals position peaked at $467K in Q3 2024.
34 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q3 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2025, filed 14 Nov 2025.